Skip to content
Decision-ready map
• SpO₂ is an estimate, not a blood test
• Risk: sometimes SpO₂ reads high when true oxygen is low
• Ask: how was the device tested across skin tones?
• Safety: symptoms override numbers + clear escalation plan
(1) What it is
A pulse oximeter is the sensor that shows an oxygen saturation number (SpO₂). It uses light to estimate oxygen in blood. It is not the same as a blood test (arterial blood gas) that measures SaO₂ by co‑oximetry. Research has shown that for some people, some devices can read higher than the true oxygen level.
(2) Who it helps
This brief is for patients and families participating in research studies or clinical programs that include pulse oximetry, including home monitoring, and for anyone who wants to know what questions protect safety and fairness.
(3) What evidence exists
In large studies comparing SpO₂ to SaO₂, some patients had true low oxygen (SaO₂ < 88%) even when SpO₂ looked acceptable (92–96%). This happened more often in Black than White patients in studied cohorts. Other health-system studies show similar patterns and link discrepant readings to outcomes. A 2024 systematic review concludes that overestimation in darker skin tones is commonly reported, though it varies by device and study design. The FDA has publicly proposed updated recommendations to improve pulse oximeter performance across skin tones.
(4) Translation barriers
Different devices behave differently, and many studies do not identify the exact model. Many factors affect readings for anyone—cold hands, poor circulation, movement, nail cosmetics, and placement. People may also receive unclear guidance about what to do when symptoms and numbers disagree.
(5) Equity/safety checks
Do not rely on one number alone if you feel worse. If you have shortness of breath, chest pain, confusion, faintness, or blue lips/nails, seek medical advice even if SpO₂ looks normal. In studies, ask how mismatches are handled and whether confirmatory tests are used when needed. Ask whether the study reports results across different skin tones.
(6) Decision questions
• What device model is being used, and is it a medical device or a consumer wellness product?
• Has it been tested across a range of skin tones, and will results be reported across groups?
• If symptoms worsen but SpO₂ looks ‘okay,’ what is the escalation plan?
(7) Practical next steps
Request a plain‑language information sheet describing device limitations and safety steps. If using a home oximeter, take readings correctly (warm hands, stay still, proper placement) and repeat rather than acting on a single value. Keep the focus on symptoms and follow-up, not on the number alone.
(8) References
https://doi.org/10.1056/NEJMc2029240
https://doi.org/10.1016/j.bja.2024.01.023
https://www.fda.gov/news-events/press-announcements/fda-proposes-updated-recommendations-help-improve-performance-pulse-oximeters-across-skin-tones